Term Name:	alpha-Neup5Ac-(2->8)-alpha-Neup5Ac-(2->8)-beta-Neup5Ac
Synonyms:	(6R)-5-acetamido-6-[(1S,2R)-2-({(6R)-5-acetamido-6-[(1S,2R)-2-({(6R)-5-acetamido-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-beta-L-threo-hex-2-ulopyranonosyl}oxy)-1,3-dihydroxypropyl]-3,5-dideoxy-beta-L-threo-hex-2-ulopyranonosyl}oxy)-1,3-dihydroxypro, 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->8)-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->8)-5-acetamido-3,5-dideoxy-D-glycero-beta-D-galacto-non-2-ulopyranosonic acid, alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->8)-beta-Neu5Ac, N-acetyl-alpha-neuraminyl-(2->8)-N-acetyl-alpha-neuraminyl-(2->8)-N-acetyl-beta-neuraminic acid, Neu5Aca2-8Neu5Aca2-8Neu5Acb, Neu5Acalpha2-8Neu5Acalpha2-8Neu5Acbeta, O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2->8)-O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2->8)-5-(acetylamino)-3,5-dideoxy-D-glycero-beta-D-galacto-2-nonulopyranosonic acid, Sia3
Definition:	α-Neup5Ac-(2→8)-α-Neup5Ac-(2→8)-Neup5Ac in which the sialyl residue at the reducing end has β anomeric configuration.
Ontology:	ChEBI [CHEBI:65105]  ( EBI )